Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Oxis International Inc announces plans to enter Cannabis Biotech Sector, changes to board


Thursday, 31 Jul 2014 10:33am EDT 

Oxis International Inc:Says management has changed the business and plans to enter the cannabis biotech space.To support the change of business, the company completed a $1.425 mln financing.Anthony Cataldo has joined the OXIS board and will serve as Chairman of the board.Just completed financing of $1.425 mln will be used to bring its required SEC filings to current status, increase marketing of OXIS nutraceutical products, and investigate possible business acquisitions in the nutraceutical and/or marijuana sector. 

Latest Developments for Oxis International Inc

Company Quote

0.0192
-7.0E-4 -3.52%
21 Nov 2014